SRC and cancer: In line with these findings, the phosphorylation of β-catenin and α-catenin downstream of tyrosine kinase receptor and/or src activation is emerging as a Wnt-independent pathway that promotes β-catenin transcriptional activation and migration of cancer cells (Ji et al., 2009; Xi et al., 2012).